. These findings suggested that the malignant transformation leading to the development of MM already occurred in a precursor of the plasma cell. Further support for this hypothesis was offered by the observation of chromosomal abnormalities in plasma cells as well as in cells with a B-lymphocyte phenotype of a patient with plasma cell leukaemia (MacKenzie et al., 1985) . These chromosomal abnormalities showed a similarity with those reported in cases of MM. However, functional proof of the participation of idiotype-bearing B-cells in the myeloma clone has not yet been achieved. In vitro stimulation of idiotype-bearing B-cells in the presence of mitogens such as pokeweed mitogen or Staphylococcus aureus did not lead to a subsequent differentiation of these cells into a more mature Ig-secreting phenotype (Peest et al., 1984; Bloem, 1985) . Moreover, it had been suggested by other investigators that the idiotype-bearing lymphocytes in MM were in fact T-lymphocytes binding the myeloma-Ig by Fc-receptors with specificity for its isotype (Hoover et al., 1981) . Recently, myeloma precursors of lymphoid morphology that lacked surface and cytoplasmic Ig, but expressed the acute lymphoblastic leukaemia antigen (CALLA) were identified in the BM of patients with MM. In vitro stimulation of these cells with the phorbol ester 12-0-tetradecanoyl-phorbol-13 acetate (TPA) resulted in their transformation into plasma cells that synthesized the myeloma-specific Ig (Caligaris-Cappio et al., 1985). This observation indicated the existence of a functional relationship between more differentiated MM-cells and their precursors. However, the exact role of the idiotypebearing B-lymphocyte has not become clear in that study. A suitable experimental animal model for MM is a prerequisite for detailed studies on the basic biological mechanisms of this neoplasm. Recently, spontaneous multiple myeloma developing in a number of aging C57BL/KaLwRij mice has been observed (Radl et al., 1985a). This mouse MM resembles the human disease in several respects. In contrast with the induced mouse plasmacytomas, it is of spontaneous origin and the MM cells are predominantly located in the BM; a circulating monoclonal myeloma protein reflects the extent of the tumour load, and, in many cases, the MM is complicated by severe osteolytic bone destruction (Radl et al., 1985a). Among the different established transplantable ST MM lines, the 5T2 MM has been studied most extensively (Radl et al., 1985b 
Multiple myeloma (MM) is generally regarded as a malignant monoclonal proliferative disorder of immunoglobulin (Ig)-secreting plasma cells predominantly located in the bone marrow (BM). However, there is increasing evidence that less differentiated B-cells are also part of the myeloma cell clone. Neoplastic cells of transplanted murine plasmacytomas have been demonstrated to differentiate from small non-secreting clonogenic cells to large plasmacytoid cells secreting the homogenous Ig (Rohrer et al., 1977; Daley, 1981) . In man, precursor cells expressing the myeloma idiotype in various stage of differentiation were demonstrated in the peripheral blood and in the BM (reviewed in Mellstedt et al., 1982; Mellstedt et al., 1984; Lokhorst et al., 1985) . These findings suggested that the malignant transformation leading to the development of MM already occurred in a precursor of the plasma cell. Further support for this hypothesis was offered by the observation of chromosomal abnormalities in plasma cells as well as in cells with a B-lymphocyte phenotype of a patient with plasma cell leukaemia (MacKenzie et al., 1985) . These chromosomal abnormalities showed a similarity with those reported in cases of MM. However, functional proof of the participation of idiotype-bearing B-cells in the myeloma clone has not yet been achieved. In vitro stimulation of idiotype-bearing B-cells in the presence of mitogens such as pokeweed mitogen or Staphylococcus aureus did not lead to a subsequent differentiation of these cells into a more mature Ig-secreting phenotype (Peest et al., 1984; Bloem, 1985) . Moreover, it had been suggested by other investigators that the idiotype-bearing lymphocytes in MM were in fact T-lymphocytes binding the myeloma-Ig by Fc-receptors with specificity for its isotype (Hoover et al., 1981) . Recently, myeloma precursors of lymphoid morphology that lacked surface and cytoplasmic Ig, but expressed the acute lymphoblastic leukaemia antigen (CALLA) were identified in the BM of patients with MM. In vitro stimulation of these cells with the phorbol ester 12-0-tetradecanoyl-phorbol-13 acetate (TPA) resulted in their transformation into plasma cells that synthesized the myeloma-specific Ig (Caligaris-Cappio et al., 1985) . This observation indicated the existence of a functional relationship between more differentiated MM-cells and their precursors. However, the exact role of the idiotypebearing B-lymphocyte has not become clear in that study. A suitable experimental animal model for MM is a prerequisite for detailed studies on the basic biological mechanisms of this neoplasm. Recently, spontaneous multiple myeloma developing in a number of aging C57BL/KaLwRij mice has been observed (Radl et al., 1985a) . This mouse MM resembles the human disease in several respects. In contrast with the induced mouse plasmacytomas, it is of spontaneous origin and the MM cells are predominantly located in the BM; a circulating monoclonal myeloma protein reflects the extent of the tumour load, and, in many cases, the MM is complicated by severe osteolytic bone destruction (Radl et al., 1985a) . Among the different established transplantable ST MM lines, the 5T2 MM has been studied most extensively (Radl et al., 1985b 
Mice
Male and female C57BL/KaLwRij mice from the colony of the TNO Institute for Experimental Gerontology were used in all experiments. They were maintained under conventional conditions. Detailed information on husbandry, health status, survival data, and age-associated pathology of this strain has been published elsewhere (Van Zwieten et al., 1981) .
5T2 MM line
The 5T2 MM originated spontaneously in an aging Br. J. Cancer (1987), 56, 555-560 kl---" The Macmillan Press Ltd., 1987 C57BL/KaLwRij mouse (Radl et al., 1979) . This MM has since been propagated by i.v. transfer of BM or spleen cells into young recipients of the same strain. The 5T2 MM used for this study was in its 22nd transplantation generation. Cell fractionation 5T2 MM BM cels were separated on the basis of differences in their sedimentation velocity according to Miller (Miller, 1984 (Visser et al., 1980; Boersma et al., 1985) .
Preparation of cells for morphological examination Glass slides with cells from the different fractions were prepared using a cytospin centrifuge (Hijmans et al., 1969) . The cell preparations were stained with May-GrunwaldGiemsa and examined by light microscopy. MM is shown at 6, 12, and 18 weeks from the day of transplantation. In each figure, the total 5T2 MM BM sedimentation profile is indicated (full continuous line).
Mice which received cells with a sedimentation rate of -8mmh-' developed a detectable MM already at 6 weeks after transplantation. In contrast, transplantation of cells with a sedimentation rate <5mmh-1 resulted in the development of 5T2 MM only after 18 weeks. surface membrane. After separation of the 5T2 MM BM suspension, the highest proportion (16-39%) of surface membrane 5T2 MM-idiotype-positive cells was present within the fractions containing the larger cells, i.e., the cells with a sed. rate exceeding 6.5mm h-1. The fractions with the smallest cells (sed. rate <3 mm h-1) contained a higher percentage (16-19%) of 5T2 MM-idiotype-positive cells than the fractions with cells of intermediate size (sed. rate between 3 and 6mmh-1) (6-12%) (Figure 3) .
Three distinct peaks were present in the distribution pattern of the DNA content of unfractionated 5T2 MM BM cells (Figure 4 ): two peaks representing the majority of the cells and a small third one. The cells within the first peak expressed the same fluorescence intensity as the non-cycling cells (in GO/GI phase) of normal BM (=2n). The second peak was located at -1.75 times the fluorescence intensity of the first one (= 3.5 n). The position of this peak in the DNAdistribution curve corresponded with that of the cycling cells in the late S-phase in the DNA-distribution curve of normal Sedimentation rate (mm h 1) BM. The third peak was located at 2 times the fluorescence intensity of the second peak (7n). Individual cell fractions obtained by the velocity sedimentation procedure contained different numbers of cells with DNA contents of 3.5n and 7n. Within the fractions with larger cells (sed. rate exceeding 6mmh-1), an increase in the proportion of cells with a DNA content of 3.5n was observed as compared with the unseparated 5T2 MM BM cells and with the fractions containing cells with sed. rates <6mmh-1 ( Figure 5 ). An increase in the proportion of cells with a DNA content of 3.5 n was also observed in the fractions with a sed. rate of 3mmh-1 ( Figure 5) . A distinct third peak, representing the cells with 7 n DNA, was only observed in the DNAdistribution curves of the fractions containing cells with sed. rates exceeding 9 mmh 1, i.e., the largest cells ( Figure 5 ).
Discussion
The 5T2 MM is one of the mouse MMs which originated spontaneously in aging C57BL/KaLwRij mice (Radl et al., 1985a) . It is a suitable experimental model for studies on the nature of this malignancy. In this study, it was determined whether the morphological heterogeneity of the 5T2 MM cells as observed by histology (Radl et al., 1985b and unpublished observations) (Visser et al., 1980; Miller, 1984) . The relatively high proportion of cells with a sed. rate exceeding 6mmh-1 which were obtained after velocity sedimentation of the 5T2 MM BM cell population reflected the presence of large abnormal myeloma cells. The first peak in the 5T2 MM BM DNA-distribution curve corresponds with non-cycling normal BM cells; the second peak is located at about 1.75 times the fluorescence intensity of the first one, and the third peak represents cells with twice the fluorescence intensity of the second peak.
A number of at least 104 events (cells) was analysed for the determination of each DNA-histogram.
Intravenous transfer of cells from fractions with sed. rates of a very broad range (from 3 to -11 mm h -1) into syngeneic recipient mice resulted in the development of 5T2 MM. However, 5T2 MM BM cells with a sed. rate of 8mmh-1 required a shorter period of time to develop into an overt myeloma as compared with the unfractionated 5T2 MM BM cells or cells from the other fractions. This indicated that the fractions containing cells with a sed. rate of 8 mmh-' included more of the cycling tumour cells than the other fractions. The increase in time interval between transplantation of the smaller cells (sed. rate between 3 and 5mmh-1) and development of the 5T2 MM might be explained by the assumption that these cells were 5T2 MM cells in an earlier stage of differentiation. The small cells apparently differentiated into a more mature stage before they began to proliferate. Contamination of the fractions Sedimentation rate (mm h-1) Figure 5 Distribution of all 5T2 MM cells (A) and of cycling 5T2 MM cells (-) according to their DNA content within fractions obtained by velocity sedimentation. All 5T2 MM cells were calculated as the proportion of cells with a DNA content exceeding 2 n minus the proportion of cycling non-myeloma BM cells. The latter proportion was calculated by assuming that the proportion of cycling normal BM cells in 5T2 MM BM and in normal mouse BM was identical.
The 5T2 MM cells with a DNA content exceeding 3.5 n were assumed to reflect the cycling 5T2 MM cells in S/G2/M phase.
The sedimentation velocity profile of total 5T2 MM BM cells is indicated (full continuous line).
containing the smaller cells with large cells cannot be totally excluded. However, this is unlikely because corresponding results were obtained in three different experiments. Furthermore, examination of the cells in the different fractions by light microscopy revealed a plasmacytoid appearance of the cells from the fractions with a moderate to high sed. rate, whereas the slower sedimenting cells had a lymphoid morphology.
The distribution curve of the DNA content of 5T2 MM cells demonstrated the presence of aneuploid cells. Abnormalities in DNA content of human myeloma cells have been demonstrated by several investigators (Latreille et al., 1980; Barlogie et al., 1982; Montecucco et al., 1984) . An excellent correlation between the percentage of cells with an abnormal DNA content and the proportion of identifiable plasma cells in the bone marrow of MM patients has been reported (Latreille et al., 1980) . The investigators concluded that cellular DNA content is a useful marker for estimation of the myeloma cell mass. In the human situation, the focal distribution of the myeloma cells within the BM compartment complicates a reliable assessment of the percentage of tumour cells by DNA-distribution analysis of the BM cells from BM aspirates or biopsies. A high proportion of the total BM compartment of 5T2 MM-bearing mice is, however, available for processing, thereby increasing the chance for an accurate determination of the percentage of aneuploid cells. The cells with a DNA content of 2 n and 4n in the 5T2 MM BM population were assumed to be normal BM cells in, respectively, the GO/Gl-and G2/M-phase of the cell cycle. The aneuploid cells containing 3.5n and 7n DNA were considered to be, respectively, the non-cycling and cycling (G2/M-phase) myeloma cells (with the exception of the cycling cells with a normal DNA content in the S-phase which also contain -3.5 n DNA). The aneuploid cells with a DNA content between 3.5 n and 7n were regarded as being the 5T2 MM cells in the S-phase of the cell cycle. The unfractionated 5T2 MM BM cell population contained about 20% of surface membrane 5T2 MM-idiotypepositive cells. Nearly 40% of the unfractionated 5T2 MM BM cells were considered to belong to the myeloma clone on the basis of their aneuploidy. This indicates that only half of these cells expressed the 5T2 MM-idiotype on their surface. The hypothesis that the heterogeneity of the 5T2 MM cell population is at least in part a reflection of differences in maturity of the myeloma cells is supported by the variety in the percentages of surface 5T2 MM-idiotype-positive cells in the different fractions. Matured plasma cells do not bear Igmolecules on their surface membrane (Mellstedt et al., 1984) . The idiotype-positive cells of the large cell fractions might have a plasmablastic phenotype.
It may be concluded that small 5T2 MM cells (sed. rates between 2.5 and 3.5mmh-1) are less mature, nonproliferating myeloma cells, presumably of the B-lymphocyte phenotype. This is supported by the following observations: (a) typical myeloma cells are in general of larger size than precursor cells of the B-cell lineage, i.e., the immature and mature B-lymphocytes (Daley, 1981) ; (b) the increase in proportion of tumour cells within the small cell fractions paralleled to a certain degree the increase in proportion of surface membrane 5T2 MM-idiotype-positive cells in these fractions. This finding probably represented an increase in the percentage of 5T2 MM-idiotype bearing B-lymphocytes; (c) a substantial number of cycling cells containing 7n DNA was not present within the small cell fractions. The conclusions of several investigators that precursor cells belong to the neoplastic clone in the mouse plasmacytoma and human MM are in agreement with the findings in this study (Rohrer et al., 1977; Daley, 1981; Mellstedt et al., 1982 Mellstedt et al., , 1984 Lokhorst et al., 1985) .
In conclusion, the morphological heterogeneity of the 5T2 MM BM cell population reflects the existence of subsets of 5T2 MM cells in different stages of differentiation. The 5T2 MM model corresponds also in this respect with MM in man. Further studies are necessary to more precisely characterize the different precursor cells in order to define the clonogenic cell of this malignancy.
